Assessing Muscle-Related Adverse Events in Randomized Trials of Statins.
Date
2022-03-16Journal
Journal of General Internal MedicinePublisher
Springer NatureType
Article
Metadata
Show full item recordSee at
https://doi.org/10.1007/s11606-022-07485-6http://www.ncbi.nlm.nih.gov/pmc/articles/pmc8926089/
Identifier to cite or link to this item
http://hdl.handle.net/10713/18295ae974a485f413a2113503eed53cd6c53
10.1007/s11606-022-07485-6
Scopus Count
Collections
Related articles
- Statin-associated adverse effects beyond muscle and liver toxicity.
- Authors: Kiortsis DN, Filippatos TD, Mikhailidis DP, Elisaf MS, Liberopoulos EN
- Issue date: 2007 Nov
- Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis.
- Authors: Pertzov B, Eliakim-Raz N, Atamna H, Trestioreanu AZ, Yahav D, Leibovici L
- Issue date: 2019 Mar
- STOMPing forward: statins, muscle complaints and CK.
- Authors: Laaksonen R
- Issue date: 2013 Oct
- Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
- Authors: Cai T, Abel L, Langford O, Monaghan G, Aronson JK, Stevens RJ, Lay-Flurrie S, Koshiaris C, McManus RJ, Hobbs FDR, Sheppard JP
- Issue date: 2021 Jul 14
- Statins and muscle pain.
- Authors: Pergolizzi JV Jr, Coluzzi F, Colucci RD, Olsson H, LeQuang JA, Al-Saadi J, Magnusson P
- Issue date: 2020 Mar